Vascular PAR-1: activity and antagonism. - Wikidata - awgldk - TriplyDB

Vascular PAR-1: activity and antagonism.

Vascular PAR-1: activity and antagonism.

http://www.wikidata.org/entity/Q37763262

about

Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage.Platelet aggregation measurement for assessment of hemostasis failure mechanisms in patients with gastroduodenal ulcer bleeding.

P2860

Q37013189-9FF572BA-37B6-434D-BA10-FF32D1DEE809 Q37092257-823DA3F2-E009-41A4-8047-3A76284E5BB2

P2860

Vascular PAR-1: activity and antagonism.

http://www.wikidata.org/entity/Q37763262

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vascular PAR-1: activity and antagonism.

@en

Vascular PAR-1: activity and antagonism.

@nl

type

label

Vascular PAR-1: activity and antagonism.

@en

Vascular PAR-1: activity and antagonism.

@nl

prefLabel

Vascular PAR-1: activity and antagonism.

@en

Vascular PAR-1: activity and antagonism.

@nl

P1433

Q37763262-2F39CA7F-D767-4B65-82F7-CBF9783AA38E

P1476

Q37763262-D74A4DA9-8729-4CBB-982D-5C278F4966D9

P2093

Q37763262-2CB3AEEA-2514-4727-A233-43CD637C87F0

Q37763262-EAF07719-810E-46AB-8FE5-EDECD22AD87E

Q37763262-FBFD6C88-363F-41E0-A660-8941789D8AAB

P2860

Q37763262-007D1849-0C7C-4F95-A26E-FFA6CE7FDD08

Q37763262-00AEC53F-733C-418F-906B-892139C63A19

Q37763262-0F20D547-AD7F-409C-B977-15B347FE7F9C

Q37763262-13A2698A-E29A-4AF5-940D-FB9E0D56D0F0

Q37763262-13A4B81C-6A2C-4C60-A5AF-B90A37EBDD4B

Q37763262-15385156-7FDC-4C38-B5C3-01CD6A380F38

Q37763262-198B6FA7-D658-4FDF-AA8C-761B8FC8CB01

Q37763262-1DF8598B-E9D0-40A8-BF1D-ACF1110F2F98

Q37763262-1FEFC795-CF05-460C-8A4C-88F94EECDF1C

Q37763262-216DFF8B-C843-4724-B968-01A1D890D106

P304

Q37763262-048972E1-DB54-4EA2-8554-6BA74DFEE4D5

P31

Q37763262-7A3F6691-273A-4495-BC26-EFAFEED0F7CA

P356

Q37763262-34B8C72A-5F16-477C-9BC0-BB8BF43A8D1E

P433

Q37763262-A87DB9C8-18AF-407C-93A8-BDDB79AEFDFA

P478

Q37763262-DDB3211F-1923-4644-B99B-8B49416DB722

P577

Q37763262-F45402FB-9561-480D-BFED-3E2C4F089249

P5875

Q37763262-42FC7B09-7C48-4179-93B8-6B7D6342E3CD

P698

Q37763262-71D524AA-FC73-489F-B3F3-74EEC279576C

P356

J.1755-5922.2010.00140.X

P1433

Cardiovascular Therapeutics

P1476

Vascular PAR-1: activity and antagonism.

@en

P2093

David E Newby

http://www.w3.org/2001/XMLSchema#string

Ingibjörg J Guðmundsdóttir

http://www.w3.org/2001/XMLSchema#string

Ninian N Lang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood

Dabigatran versus warfarin in patients with atrial fibrillation

Protease-activated receptors in cardiovascular diseases

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Thrombin signalling and protease-activated receptors

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.

P304

349-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2010.00140.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44654695

http://www.w3.org/2001/XMLSchema#string

P698

20528879

http://www.w3.org/2001/XMLSchema#string